IPP Bureau
Healthium collaborates with Abhinav Bindra to treat sports injuries
By IPP Bureau - March 06, 2022
According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport
Sir H.N. Reliance Foundation Hospital performs complete robotic gastric bypass surgery
By IPP Bureau - March 06, 2022
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens
By IPP Bureau - March 06, 2022
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.
By IPP Bureau - March 06, 2022
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
Evonik expands production of plant-derived cholesterol in Germany
By IPP Bureau - March 06, 2022
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
AIkido Pharma improves manufacturing process for pancreatic drug
By IPP Bureau - March 04, 2022
The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
Oragenics announces positive data on Covid-19 intranasal vaccine
By IPP Bureau - March 04, 2022
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
USFDA issues final guidance on voluntary recalls
By IPP Bureau - March 04, 2022
The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem
WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site
By IPP Bureau - March 04, 2022
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP
By IPP Bureau - March 04, 2022
Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements
AbbVie acquires Syndesi Therapeutics, strengthening neuroscience portfolio
By IPP Bureau - March 04, 2022
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
New CellScape system for high-plex and high-throughput targeted spatial proteomics
By IPP Bureau - March 04, 2022
ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumour microenvironment, as well as deep immune profiling for applications in immunology, neuroscience, and infectious disease
Known Medicine partners with Duke University to predict lung cancer response to drug treatments
By IPP Bureau - March 04, 2022
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Scientific leaders signal major breakthroughs in elimination of cervical and anal cancers
By IPP Bureau - March 04, 2022
To mark International HPV Awareness Day on March 4th 2022, the International Papillomavirus Society (IPVS) has warmly welcomed two major advances in the elimination of cervical and anal cancers
MFine launches heart rate monitoring tool on its App
By IPP Bureau - March 04, 2022
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
